Digital Pathology Market (2025-2032)
The Digital Pathology Market is poised to reach $1.86 billion by 2032, exhibiting a CAGR of 8.7% from 2025 to 2032.
- Published
- Jan 2025
- Pages
- 185
- Format
- PDF + Excel
- Report ID
- MRHC - 104749
- Base year
- 2024
- 2032 · FORECAST
- $1.86B
- 2032
- $1.86B
- CAGR 2025–2032
- 8.7%
2024 baseline · 2025–2032 forecast at 8.7% CAGR · hover a bar for the value
Key highlights
The Digital Pathology Market is poised to reach $1.86 billion by 2032, exhibiting a CAGR of 8.7% from 2025 to 2032.
The hardware segment is expected to account for the largest share of the market in 2025
The large market share of this segment is attributed to the high burden of chronic diseases, the high adoption of teleconsulting, and the rising awareness about the importance of early disease diagnosis is driving the demand for digital pathology solutions.
The hospitals & clinics segment is expected to account for the largest share of the market
The growth of this regional market is attributed to the increasing geriatric population in countries such as China and India, the rising adoption of advanced healthcare solutions in developing countries, the rising disposable incomes among the population, and the rising awareness about the advantages of digital pathology.
Report summary
| Particulars | Details |
|---|---|
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2025–2032 |
| Market Size (2032) | USD 1.86 billion |
| CAGR (2025–2032) | 8.7% |
| Format | PDF, Excel & Cloud Portal · 185 pages |
| Segments Covered | By Offering: Hardware Slide Scanners Bright Field, Other Scanners, Image Analysis Software, Information Management System, Other Software · By Application: Disease Diagnosis, Drug Discovery & Development, Education & Training, Teleconsultation · By End User: Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Diagnostic Laboratories |
| Countries Covered | Europe (RoE), Asia-Pacific (RoAPAC) |
| Key Companies | Danaher Corporation, Nikon Corporation, Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd, Glencoe Software, Inc., XIFIN, Inc., PerkinElmer Inc. |
Report overview
Segments covered: offering, application, end user. Regions: Europe, Asia-Pacific.
Digital pathology entails the interpretation and management of pathology information derived from digitized glass slides. It has become a mainstream choice for routine diagnostics and drug development. The adoption of digital pathology has surged owing to its diverse advantages, such as real-time sharing of video streams and digital images. Moreover, the integration of machine learning (ML) allows image assessments beyond traditional histopathology by connecting AI with clinical data.
Furthermore, the rising adoption of digital pathology has led to the emergence of virtual pathology, creating new opportunities for teleconsulting. Moreover, computer-aided diagnosis by digital images produces more precise and accurate results than a traditional microscope offering. The technology is gaining prominence due to growing requirements in anatomical pathology applications for quantitative image analysis. These emerging imaging tools enable pathologists to conduct more consistent and accurate diagnoses.
Report infographic
Market dynamics
1 factors across 1 forceRising Prevalence of Chronic Diseases
According to the Centers for Disease Control and Prevention, chronic diseases such as cancer, diabetes, and cardiovascular diseases are major causes of disability and death in the U.S. and account for USD 4.1 trillion of the nation’s annual healthcare costs. As of July 2022, six in ten adults have a chronic disease in the U.S. and four in ten suffer from two or more chronic diseases.
As per the data published by the WHO, it is expected that by 2032, 1 in six people globally will be more than 60 years old. By 2050, the global population aged 60 and above is likely to increase to nearly 2.1 billion. Additionally, the number of individuals aged 80 or older is expected to reach 426 million between 2020 and 2050. The prevalence of chronic diseases is higher among the elderly population. Thus, the rising aging population and the subsequent increase in cancer & other chronic diseases are expected to drive the demand for more precise and accurate diagnosis, driving the growth of the digital pathology market.
Table of contents
11 chapters · 90 sections · 185 pages · click to expandSegmental analysis
| Segment | Largest share (2025) | Fastest growth (2025–2032) |
|---|---|---|
| By Offering | Hardware | — |
| By Application | Large market share of this | — |
| By End User | Hospitals & clinics | — |
By Offering
- The hardware segment is expected to account for the largest share of the market in 2025
- The large market share of this segment is attributed to the increasing number of laboratories, the rising number of patients requiring in vitro tests, and the growing need for timely and accurate disease treatment.
- The hardware segment is further subsegmented into tissue microarrays, scanners, and other hardware.
- The large market share of the hardware segment is attributed to the increased demand for scanners for R&D activities, the rising prevalence of chronic diseases, and the high adoption of digital pathology systems.
By Application
- The large market share of this segment is attributed to the high burden of chronic diseases, the high adoption of teleconsulting, and the rising awareness about the importance of early disease diagnosis is driving the demand for digital pathology solutions.
By End User
- The hospitals & clinics segment is expected to account for the largest share of the market
- The large market share of this segment is attributed to the rising number of hospitals & clinics, the rise in the number of hospitalizations for the treatment of chronic diseases, and the increasing installation of digital pathology systems and tools in the healthcare sector in developed countries.
- Additionally, strategic collaborations among hospitals and key market players for launching advanced products are expected to drive the market’s growth.
- For instance, in May 2022, Sectra AB (Sweden) signed an agreement with UniHA, a cooperative of French public hospitals, for Spectra’s digital pathology.
- This agreement enabled the hospitals to purchase Sectra’s solution without undertaking a public tender process on preconditioned terms and conditions.
Geographic analysis
Asia-Pacific
Fastest growthThe growth of this regional market is attributed to the increasing geriatric population in countries such as China and India, the rising adoption of advanced healthcare solutions in developing countries, the rising disposable incomes among the population, and the rising awareness about the advantages of digital pathology. Asia-Pacific: Fastest-growing Regional Market
Competitive landscape
- Danaher Corporation
- Nikon Corporation
- Koninklijke Philips N.V.
- F. Hoffmann-La Roche Ltd
- Glencoe Software, Inc.
- XIFIN, Inc.
- PerkinElmer Inc.
Frequently asked questions
This study offers a detailed assessment of the digital pathology market and provides the sizes & forecasts for the digital pathology market based on offering, application, and end user. The report also offers the value analysis of various segments and subsegments of the digital pathology market at the regional and country levels.
Cite this report
Meticulous Research. (2025). Digital Pathology Market - Global Opportunity Analysis and Industry Forecast (2025-2032) (Report No. MRHC - 104749). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/digital-pathology-market-5433